HBM Healthcare Investments AG

HBM PartnersAsset ManagementSwitzerland

83% match

HBM Partners is a Swiss healthcare asset manager and investor that provides venture, growth, and buy-out financing to private and public companies in the biopharma, medtech, diagnostics, and healthcare sectors. The firm advises specialized equity investment funds and supports entrepreneurial companies by providing capital and strategic industry expertise.

Private Equity Holding AG implements a comprehensive investment strategy, primarily through fund-of-funds, secondary indirect investments, and carefully selected direct co-investments. Its fund-of-funds approach spans various categories, including venture, buyout, special situation, secondary, and balanced funds, with a specific exclusion of very early-stage venture capital and mega-buyout funds. Within its venture fund allocations, a strong emphasis is placed on technology sectors such as Internet, telecommunications, information technology, life sciences, and other high-tech areas like semiconductors and electronics. For direct participation, the company typically opts to co-invest alongside partner funds or offer pre-IPO financing in the form of convertible loans. Its investment scope is wide-ranging, encompassing businesses at diverse stages and scenarios, from mid-to-late venture, middle-market, and developmental phases, to management buyouts and buy-ins, succession issues, bridge financings, spin-offs, distressed and turnaround situations, and mature companies. It also considers Private Investment in Public Equity (PIPES). Geographically, Private Equity Holding AG focuses on developed European markets, with particular attention to Switzerland, Germany, France, and the United Kingdom, alongside Central and Eastern Europe, Israel, and the United States. For expansion or development capital, it targets companies generating annual revenues exceeding $1 million. The firm channels most of its investments through offshore entities and generally aims to secure a controlling interest.

Castle Private Equity AG operates as an evergreen investment vehicle. Its strategy involves both allocating capital to other private equity funds (fund of funds) and making direct equity investments. The firm targets a broad spectrum of private equity strategies, encompassing large, late-stage, small, and mid-market buyouts, as well as growth capital, distressed debt, and mezzanine financing opportunities. A smaller segment of its portfolio is allocated to direct participations in private companies, covering early and late-stage venture capital, and Special Situations. Investment structures include commitments to newly formed funds and acquiring existing fund interests in the secondary market, with secondary investing being a core component of its approach. The company seeks prospects across manufacturing, biotechnology, life sciences, retail, distribution, media, telecommunications, and information technology sectors. While maintaining a global investment scope, its primary geographical emphasis is on the developed private equity markets of Europe and North America. Castle Private Equity AG typically aims for majority ownership stakes, securing two board representatives, and generally holds investments for a period of ten years.

HG CAPITAL TRUST PLCHGT · Asset ManagementLondon, United Kingdom

70% matchPublic

HgCapital Trust plc (2017) strategically allocates capital to a diverse range of opportunities, encompassing direct investments in both publicly traded and privately held companies, as well as participations in fund-of-funds arrangements. The trust permits its entire gross asset base (100%) to be exposed to unlisted investments. However, it imposes a strict limit, ensuring that no individual direct or indirect investment in an unlisted company or closed-ended fund exceeds 15% of its gross assets. The primary focus for its direct investments lies in middle-market buyouts across the Technology, TMT, Services, and Industrials Technology sectors, targeting businesses with enterprise values between £80 million (approximately $97.43 million) and £500 million (approximately $608.95 million). It also seeks lower mid-market buyout prospects specifically within the TMT sector, focusing on companies valued from £20 million (approximately $24.35 million) to £80 million (approximately $97.43 million). Beyond these, the fund explores direct investments in hospitality (hotels, restaurants, leisure), consumer durables and apparel, various service industries, and renewable energy. Geographically, HgCapital Trust prioritizes investments within Europe, with a distinct emphasis on Northern Europe, including the United Kingdom, Germany, France, the Benelux region, and the Nordics, alongside other European territories. The trust typically commits between £100 million (approximately $202.89 million) and £500 million (approximately $1014.45 million) to each of its portfolio companies. For its fund-of-funds segment, it specifically invests in limited partnership vehicles overseen by HgCapital. A cornerstone of its investment philosophy is to secure a majority ownership stake in the businesses it supports.

Hamilton Lane Incorporated operates as an investment management firm, specializing in both direct investments and fund-of-funds strategies. The firm offers a comprehensive range of services, including: Tailored Separate Accounts: Structured as single-client vehicles, these are customized to meet specific client requirements. Specialized Investment Strategies: This category encompasses offerings such as fund-of-funds, secondary market transactions, co-investments, Taft-Hartley plans, and distribution management. Advisory Services: Hamilton Lane provides expert guidance, covering thorough due diligence, strategic portfolio planning, continuous monitoring, and performance reporting. Reporting and Analytics: The company also delivers advanced solutions for data reporting and analysis. For its direct investments, Hamilton Lane targets a diverse array of companies, participating across various stages of their lifecycle. This includes early, mid, and late-stage venture capital, mature businesses, and growth equity opportunities. The firm's interests also extend to emerging growth companies, distressed debt scenarios, later-stage financing, corporate turnarounds, bridge financing, mezzanine capital, and leveraged buyouts, primarily within the middle market segment. When pursuing a fund-of-funds approach, Hamilton Lane allocates capital to a variety of specialized funds. These include those focused on mezzanine, venture capital, private equity, turnaround, secondary investments, real estate, and special situations. Beyond specific asset classes, the firm's investment scope spans multiple sectors, including real estate, technology, healthcare, education, natural resources, energy, essential consumer goods, cleantech, environmental initiatives, community development, and financial empowerment projects. Geographically, Hamilton Lane's private equity investments demonstrate a wide global footprint, with its presence extending across North America (including the United States), Latin America, Western Europe (including the United Kingdom), the Middle East, Africa, Asia (including Japan), and Australia. The firm typically aims to commit between $1 million and $100 million per company, often prioritizing the acquisition of a majority ownership stake in its portfolio companies. Established in 1991, Hamilton Lane Incorporated maintains its headquarters in Conshohocken, Pennsylvania, complemented by a network of additional offices across Europe, North America, and Asia.

Altamir SCA, formerly known as Altamir Amboise, operates as a private equity firm that engages in both direct equity investments and fund-of-fund strategies, primarily targeting small and medium-sized companies. For its direct investment activities, the firm focuses on middle-market opportunities, encompassing buyout and growth capital financing. A particular area of interest is the acquisition of underdeveloped divisions within larger corporations. When investing in other funds, Altamir gravitates towards private equity vehicles dedicated to growth capital and leveraged buyout transactions. The firm's sectorial interests are diverse, spanning healthcare, technology, media, and telecommunications (TMT), digital enterprises, various service industries, and retail and distribution. Within healthcare, it specifically seeks high-growth potential in areas such as health services (e.g., hospitalization, home care, medical analysis), medical devices, niche pharmaceutical laboratories, and related sectors like dermo-cosmetics, galenic development, and data/service providers for health organizations. Broader retail, consumer, business, and financial services also fall within its purview. Geographically, Altamir seeks unlisted companies primarily across Europe, including Belgium, France, Luxembourg, Switzerland, Monaco, Italy, the Netherlands, Germany, and French-speaking Europe, alongside the United States, Canada, and key emerging markets like China, India, and Brazil. For small and mid-cap companies, its preference lies in Continental Europe, with a strong focus on France, Italy, and the Benelux region. For larger enterprises, its investment reach extends to Europe, North America, and emerging economies such as China, India, and Brazil. Altamir typically targets small and mid-cap companies with an enterprise value ranging from €50 million ($55.36 million) to €500 million ($553.6 million). For larger companies, the enterprise value for investment falls between €500 million ($553.60 million) and €3,000 million ($3,321.62 million). When investing in funds, the firm aims for a majority ownership stake or a leading shareholder position. Altamir aligns its investment and divestment processes with the private equity funds of Apax Partners France and Amboise Investissement under identical conditions, and also directly invests in funds managed or advised by Apax Partners France and Apax Partners LLC. The firm's objective is to exit its investments within a five-year timeframe, and all capital deployment is made from its own balance sheet. Altamir SCA was established in 1995 and is based in Paris, France.